In addition, in preclinical studies, ASCL1 was shown to stimulate proliferation and migration in SCLC cells by targeting CDK5,18 which is exemplified in our data that ASCL1 high expression is significantly correlated with TNM stage, lymphatic metastasis and nerve invasion. This evidence concerns the gene ASCL1 and small cell lung carcinoma.